Narrative Equity Fund for Rare Disease Awareness

With 95% of rare diseases lacking therapeutics, the only stories that typically get financial backing are the 5% tied to biopharma interests. To ensure that all rare disease voices are heard, we need stories that are free from corporate influence. This independence preserves authenticity and prevents the audience from feeling that stories are being used for corporate profit. The Narrative Equity Fund exists to make this possible.